HK1185230A1 - 含有咪唑肽和槲皮素糖苷的組合物 - Google Patents

含有咪唑肽和槲皮素糖苷的組合物

Info

Publication number
HK1185230A1
HK1185230A1 HK13112868.9A HK13112868A HK1185230A1 HK 1185230 A1 HK1185230 A1 HK 1185230A1 HK 13112868 A HK13112868 A HK 13112868A HK 1185230 A1 HK1185230 A1 HK 1185230A1
Authority
HK
Hong Kong
Prior art keywords
composition
quercetin glycoside
imidazole peptide
imidazole
peptide
Prior art date
Application number
HK13112868.9A
Other languages
English (en)
Inventor
Nozomi Kitahara
Aki Tsujimoto
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of HK1185230A1 publication Critical patent/HK1185230A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86—Addition of bitterness inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK13112868.9A 2012-03-08 2013-11-18 含有咪唑肽和槲皮素糖苷的組合物 HK1185230A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012051946 2012-03-08

Publications (1)

Publication Number Publication Date
HK1185230A1 true HK1185230A1 (zh) 2014-02-14

Family

ID=49116178

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13112868.9A HK1185230A1 (zh) 2012-03-08 2013-11-18 含有咪唑肽和槲皮素糖苷的組合物

Country Status (5)

Country Link
JP (1) JP5324000B1 (zh)
CN (1) CN103300278B (zh)
HK (1) HK1185230A1 (zh)
TW (1) TWI517793B (zh)
WO (1) WO2013132668A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014267299B2 (en) 2013-05-14 2019-07-18 Mars, Incorporated Joint care composition
JP6310708B2 (ja) * 2014-01-28 2018-04-11 花王株式会社 固形状組成物
GB201414910D0 (en) * 2014-05-23 2014-10-08 Mars Inc Composition
JP6676292B2 (ja) * 2015-06-23 2020-04-08 三栄源エフ・エフ・アイ株式会社 口腔用組成物
EP3442517A1 (en) * 2016-04-14 2019-02-20 Lucey, Michael Combinational compositions and methods of use thereof
JP7134607B2 (ja) * 2016-08-25 2022-09-12 大正製薬株式会社 錠剤
JP2018090640A (ja) * 2018-03-16 2018-06-14 花王株式会社 固形状組成物
CN108926506B (zh) * 2018-09-27 2022-02-25 中国农业科学院麻类研究所 黄麻叶中黄酮醇类组分的提取方法及其提取物和应用
US20220183338A1 (en) * 2019-02-20 2022-06-16 Suntory Holdings Limited Protein-containing oral composition and method for improving flavor of protein-containing oral composition
AU2020406604A1 (en) * 2019-12-17 2022-07-07 Suntory Holdings Limited Composition for promoting chondroitin sulfate synthesis
JP6956846B1 (ja) * 2020-12-17 2021-11-02 ダイドーグループホールディングス株式会社 腰痛改善剤および体幹筋力向上剤
JP7080388B1 (ja) 2021-10-29 2022-06-03 ダイドーグループホールディングス株式会社 歩行機能における動的バランスの改善剤、転倒不安感の軽減剤および移動機能の低下を有する人に対する歩行機能改善剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01110616A (ja) * 1987-10-22 1989-04-27 Naoki Suzuki 入浴助剤
EP0565313B1 (en) * 1992-04-02 1997-07-30 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method to improve taste preference of pine extract, and orally administrable product obtained thereby
JPH07265008A (ja) * 1994-03-29 1995-10-17 Ajinomoto Co Inc こく味付与剤
JPH0899861A (ja) * 1994-09-30 1996-04-16 Kose Corp 皮膚外用剤
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
JP3416104B2 (ja) * 1999-12-20 2003-06-16 雪印食品株式会社 食品の抗酸化能を増強させる方法及び食品用の抗酸化能増強剤
JP2002101843A (ja) * 2000-10-02 2002-04-09 Ajinomoto Co Inc 煮物用甘味料組成物
JP2004059522A (ja) * 2002-07-30 2004-02-26 Fancl Corp 持続性ルチン製剤
JP2005006615A (ja) * 2003-06-17 2005-01-13 Crescendo Corporation 茶節
JP2006158274A (ja) * 2004-12-06 2006-06-22 National Agriculture & Food Research Organization ダッタンソバ子実を用いたスプラウト
JP4635159B2 (ja) * 2005-09-05 2011-02-16 独立行政法人農業・食品産業技術総合研究機構 Ｇａｂａを高濃度に含有する食用植物体及びその製造方法
US20080193591A1 (en) * 2005-12-26 2008-08-14 Yaizu Suisankagaku Industry Co., Ltd. Taste Improving Agent for Food and Beverage Containing Potassium Chloride, Process for Producing Food and Beverage Containing Potassium Chloride and Food and Beverage Containing Potassium Chloride Produced by the Process
JP2007197363A (ja) * 2006-01-26 2007-08-09 Beta Shokuhin Kk 栄養補助剤
US20090214712A1 (en) * 2008-02-21 2009-08-27 The Coca Cola Company Milk-Based Beverage and Method for Preventing Off-Flavors in a Milk-Based Beverage
US20110124577A1 (en) * 2008-07-30 2011-05-26 Suntory Holdings Limited Preparation for oral administration comprises quercetin glycoside and a water-based solvent extract of cartilage containing chondroitin sulfate
CN103037710B (zh) * 2010-04-15 2016-08-10 卓莫赛尔公司 用于减小或消除苦味的化合物、组合物和方法

Also Published As

Publication number Publication date
JPWO2013132668A1 (ja) 2015-07-30
WO2013132668A1 (ja) 2013-09-12
JP5324000B1 (ja) 2013-10-23
CN103300278A (zh) 2013-09-18
TW201347681A (zh) 2013-12-01
CN103300278B (zh) 2015-01-28
TWI517793B (zh) 2016-01-21

Similar Documents

Publication Publication Date Title
HUS2200034I1 (hu) Glikokonjugációs eljárások és kompozíciók
HK1185230A1 (zh) 含有咪唑肽和槲皮素糖苷的組合物
IL238958A0 (en) Glutamase inhibitors, preparations containing them and their uses
HK1214970A1 (zh) 含有低聚果糖和槲皮素糖苷的組合物
IL238959A0 (en) Glutamase inhibitors, preparations containing them and their uses
IL269024A (en) The trains containing PEG and ASCORBATE
IL236268A0 (en) Preparations for mucosal administration and their uses
EP2556430A4 (en) VIRTUAL APPLICATION EXTENSION POINTS
IL232217A (en) Derivatives of Azul, pharmaceutical preparations containing them and their use
GB201314312D0 (en) Composition and delivery system
ZA201302113B (en) Caspofungin composition
EP2708532A4 (en) 4-AMINOQUINAZOLINE DERIVATIVES AND USES THEREOF
IL236712A0 (en) Di-teri-heteroaryl derivatives, preparations containing them and their uses
EP2889307A4 (en) ALPHA-CONOTOXIN PEPTIDE AND MEDICAL COMPOSITION AND THEIR OBJECTIVE
EP2874641A4 (en) COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF
HK1204948A1 (zh) 放射線滅菌耐性的蛋白組合物
HUE032878T2 (hu) Bõrvédõ és bõrkiegyensúlyozó készítmény
ZA201209745B (en) Compositions containing flavones and anthelmintics
TH1401005243B (th) ตำรับยาของแข็งที่มีอิมิดาโซลเพปไทด์กับเคอร์ซิตินไกลโคไซด์ผสมอยู่